Hercules Capital (HTGC) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
1 Nov, 2025Executive summary
Achieved record Q3 2025 total investment income of $138.1 million, up 10.3% year-over-year, and net investment income of $88.6 million, or $0.49 per share, with strong origination and portfolio growth.
Originations and fundings reached record highs, with $846.2 million in new commitments and $504.6 million in fundings for Q3, and $2.87 billion in commitments year-to-date.
Maintained a conservative balance sheet with over 90% first lien exposure, 97.8% floating rate loans, and robust liquidity exceeding $655 million.
Portfolio is diversified across technology and life sciences, with 78 equity and 102 warrant holdings, and strong regulatory oversight.
Assets under management grew 20.7% year-over-year to $5.5 billion, with NAV per share rising to $12.05, the highest since 2008.
Financial highlights
Q3 2025 total investment income was $138.1 million, up from $125.2 million in Q3 2024, and net investment income was $88.6 million, or $0.49 per share.
Assets under management reached $5.5 billion, and total assets grew to $4.41 billion from $3.83 billion at year-end 2024.
Return on equity for Q3 was 17.4%; GAAP effective yield 13.5%, core yield 12.5%, and net interest margin 10.8%.
Net asset value per share increased 1.8% to $12.05 at September 30, 2025.
Weighted average cost of debt was 5.1% for Q3 2025.
Outlook and guidance
Origination activity expected to remain strong through year-end, with Q4 typically robust and core yield guidance reiterated at 12%-12.5%.
Prepayments expected to be $150-$200 million in Q4; SG&A expenses for Q4 expected at $25-$26 million.
Management expects continued focus on high-growth, venture-backed companies in technology and life sciences, with a robust pipeline of $847.4 million in non-binding term sheets.
Confident in maintaining base and supplemental distributions into next year, with strong dividend coverage even in a rate reduction environment.
Focus on sustainable shareholder returns and disciplined underwriting standards.
Latest events from Hercules Capital
- Record 2025 commitments and fundings drove strong income growth and robust portfolio quality.HTGC
Q4 202513 Feb 2026 - Record Q2 results, strong liquidity, and new SBIC license drive continued portfolio growth.HTGC
Q2 20242 Feb 2026 - Record investment income, strong portfolio growth, and robust liquidity with moderate leverage.HTGC
Q3 202417 Jan 2026 - Record investment income, portfolio growth, and new 2025 supplemental distribution announced.HTGC
Q4 20245 Jan 2026 - Q1 2025 saw $77.5M NII, $1.02B commitments, and strong liquidity with stable portfolio quality.HTGC
Q1 202523 Dec 2025 - 2024 marked record growth, robust governance, and continued focus on stockholder value and ESG.HTGC
Proxy Filing1 Dec 2025 - Record financials, director elections, and key governance votes highlight strong performance.HTGC
Proxy Filing1 Dec 2025 - Shareholders will vote on directors, executive pay, auditor ratification, and share issuance flexibility.HTGC
Proxy Filing1 Dec 2025 - Record Q2 2025 investment income, portfolio growth, and strong liquidity position.HTGC
Q2 202529 Oct 2025